Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision

British Journal of Ophthalmology

Volumn 90, Issue 12, 2006, Pages 1476-1480

  Luanratanakorn, P ^b   Ratanapakorn, T ^b   Suwan Apichon, O ^b   Chuck, R S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; EYE DROPS;

ADULT; AGED; AMNION; ARTICLE; AUTOGRAFT; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PTERYGIUM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMNION; CONJUNCTIVA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PTERYGIUM; RECURRENCE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 33845241722     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.095018     Document Type: Article

References (71)

1. Rosenthal JW. Chronology of pterygium therapy. Am J Ophthalmol 1953;36:1601-16.
2. Duke-Elder SS, ed. Degenerative and pigmentary changes. In: System of ophthalmology. 3rd edn. London: Henry Kimpton, 1977:569-85.
3. Jaros PA, DeLuise VP. Pingueculae and pterygia. Surv Ophthalmol 1988;33:41-9.
4. Adamis AP, Starck T, Kenyan KR. The management of pterygium. Ophthalmol Clin North Am 1990;3:611-23.
5. Lani AH, Lani LA. Conjunctival autograft transplantation in primary pterygium. Arq Bras Oftalmol 2005;68:99-102.
6. King JJH. The pterygium. Brief review and evaluation of certain methods of treatment. Arch Ophthalmol 1950;44:854-69.
7. Dowlut MS, Laflamme MY. Les pterygions recidivants: frequence et correction par autogreffe conjonctivale. Can J Ophthalmol 1981;16:119-20.
8. Anduze AL. Merest sclera technique for primary pterygium surgery. Ophthalmic Surg 1989;20:892-3.
9. Riordan-Eva P, Kielhorn I, Ficker LA, et al. Conjunctival autografting in the surgical management of pterygium. Eye 1993;7:634-8.
10. McCoombes JA, Hirst LW, Isbell GP. Sliding conjunctival flap for the treatment of primary pterygium. Ophthalmology 1994;101:169-73.
11. Said A, Fouad ARA, Mostafa MSE, et al. Surgical management of recurrent pterygium by an operation of transposition. Bull Ophthalmol Soc Egypt 1975;68:81-4.
12. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92:1461-70.
13. Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989;96:1612-14.
14. Singh G, Wilson MR, Foster CS. Long-term follow-up study of mitomycin eye drops as adjunctive treatment for pterygia and its comparison with conjunctival autograft transplantation. Cornea 1990;9:331-4.
15. Starck T, Kenyon KR, Serrano F. Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management. Cornea 1991;10:196-202.
16. Allan BD, Short P, Crawford GJ, et al. Pterygium excision with conjunctival autografting: an effective and safe technique. Br J Ophthalmol 1993;77:698-701.
17. Chen PP, Ariyasu RG, Kaza V, et al. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995;120:151-60.
18. Hara T, Shoji E, Hara T, et al. Pterygium surgery using the principle of contact inhibition and a limbal transplanted pedicle conjunctival strip. Ophthalmic Surg 1994;25:958.
19. Guler M, Sobaci G, Ilker S, et al. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol 1994;72:721-6.
20. Figueiredo RS, Cohen EJ, Gomes JA, et al. Conjunctival autograft for pterygium surgery: how well does it prevent recurrence? Ophthalmic Surg Lasers 1997;28:99-104.
21. Rao SK, Lekha T, Mukesh BN, et al. Conjunctival autograft for primary and recurrent pterygia: technique and results. Indian J Ophthalmol 1998;46:203-9.
22. Laughrea PA, Arentsen JJ. Lamellar keratoplasty in the management of recurrent pterygium. Ophthalmic Surg 1986;17:106-8.
23. Busin M, Halliday BL, Arffa RC, et al. Precarved lyophilized tissue for lamellar keratoplasty in recurrent pterygium. Am J Ophthalmol 1986;102:222-7.
24. Suveges I. Sclerokeratoplasty in recurrent pterygium. Ger J Ophthalmol 1992;1:114-16.
25. Nakamura K, Bissen-Miyajima H, Shimmura S, et al. Clinical application of Er:YAG laser for the treatment of pterygium. Ophthalmic Surg Lasers 2000;31:8-12.
26. Barraquer MJ. Localized discontinuity of the precorneal lacrimal film. Etiology of Fuchs' marginal corneal ulcers, of progression of pterygium and of certain corneal necroses in the neighborhood of keratoprostheses and keratoplasties. Ophthalmologica 1965;150:111-22.
27. Koranyi G, Seregard S, Kopp, eds. Cut and paste: a no suture, small incision approach to pterygium surgery. Br J Ophthalmol 2004;88:911-14.
28. Keizer RJW. Pterygium excision with or without postoperative irradiation, a double-blind study. Doc Ophthalmol 1982;52:309-15.
29. Mackenzie FD, Hirst LW. Kynaston B, et al. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 1991;98:1776-81.
30. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988;95:813-21.
31. Hayosaka S, Noda S, Yamamoto Y, et al. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 1988;106:715-18.
32. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea 1994;13:411-13.
33. Rachmiel R, Leiba H, Levartovsky S. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium. Br J Ophthalmol 1995;79:233-6.
34. Cano-Parra J, Diaz-Llopis M, Maldonado MJ, et al. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 1995;79:439-41.
35. Mahar PS. Conjunctival autograft versus topical mitomycin C in treatment of pterygium. Eye 1997;11:790-2.
36. Akarsu C, Taner P, Ergin A. 5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report. Cornea 2003;22:522-6.
37. Wu H, Chen G. Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium. Yan Ke Xue Bao 1999;15:91-2.
38. Dadeya S, Kamlesh. Intraoperative daunorubicin to prevent the recurrence of pterygium after excision. Cornea 2001;20:172-74.
39. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol 1980;64:496-505.
40. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin C. Cornea 1996;15:537-40.
41. Alaniz-Camino F. The use of postoperative beta radiation in the treatment of pterygia. Ophthalmic Surg 1982;13:1022-5.
42. Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997;115:1235-40.
43. Prabhasawat P, Barton K, Burkett G, et al. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997;104:974-85.
44. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998;82:235-40.
45. Ma DHK, See LC, Liau SB, et al. Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Ophthalmol 2000;84:973-8.
46. Shimazaki J, Kosaka K, Shimmura S, et al. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 2003;110:119-24.
47. Xi XH, Jiang DY, Tang LS. Transplantation of amniotic membrane and amniotic membrane combined with limbal autograft for patients with complicated pterygium. Hunan Yi Ke Da Xue Xue Bao 2003;28:149-51.
48. Kawasaki S, Uno T, Shimamura I, et al. Outcome of surgery for recurrent pterygium using intraoperative application of mitomycin C and amniotic membrane transplantation. Nippon Gonka Gakkai Zasshi 2003;107:316-21.
49. Chandra A, Maurya OP, Reddy B, et al. Amniotic membrane transplantation in ocular surface disorders. J Indian Med Assoc 2005;103:364-6.
50. Bultmann S, You L, Spandau U, et al. Amniotic membrane down-regulates chemokine expression in human kerotocytes. Invest Ophthalmol Vis Sci 1999;40:S578.
51. Tseng SCG, Li DG, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-B receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblast by amniotic membrane matrix. J Cell Physiol 1999;179:325-35.
52. Kobayashi A, Inana G, Meller D, et al. Differential gene expression by human cultured umbilical vein endothelial cells on amniotic membrane. Presented at the 4th Ocular Surface and Tear Conference; 14 May 1999, Miami, FL, USA.
53. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14:473-84.
54. Vastine DW, Stewart WB, Schwab IR. Reconstruction of the periocular mucous membrane by autologous conjunctival transplantation. Ophthalmology 1982;89:1072-81.
55. Camara JG, dela Cruz-Rosas B, Nguyen LT. The use of a radiofrequency unit for harvesting conjunctival autografts in pterygium surgery. Am J Ophthalmol 2004;138:165-7.
56. Hilgers JHC. Pterygium: incidence, heredity and etiology. Am J Ophthalmol 1960;50:635-44.
57. Mackenzie FD, Hirst LW, Battistutta D, et al. Risk analysis in the development of pterygia. Ophthalmology 1992;99:1056-61.
58. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 2004;23:458-63.
59. Liotta LA, Lee CW, Morakis DJ. New method for preparing large surfaces of intact human basement membrane for tumor invasion studies. Cancer Lett 1980;11:141-52.
60. Campbell S, Allen TD, Moser BB, et al. The translaminal fibrils of the human amnion basement membrane. J Cell Sci 1989;94:307-18.
61. Terranova VP, Lyall RM. Chemotaxis of human gingival epithelial cells to laminin. A mechanism for epithelial cell apical migration. J Periodontol 1986;57:311-17.
62. Khodadoust AA, Silverstein AM, Kenyon KR, et al. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am J Ophthalmol 1968;65:339-48.
63. Sonnenberg A, Calafat J, Janssen H, et al. Integrin a6/b4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991;113:907-17.
64. Barcellos-Hoff MH, Aggeler J, Ram TG, et al. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 1989;105:223-35.
65. Guo M, Grinnell F. Basement membrane and human epidermal differentiation in vitro. J Invest Dermatol 1989;93:372-8.
66. Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 1991;115:1383-95.
67. Kurpakus MA, Stock EL, Jones JCR. The role of the basement in differential expression of keratin proteins in epithelial cells. Dev Biol 1992;150:243-55.
68. Boudreau N, Sympson CJ, Werb Z, et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-3.
69. Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci USA 1996;93:3500-13.
70. Fernandes M, Sangwan VS, Bansal AK, et al. Outcome of pterygium surgery: analysis over 14 years. Eye 2005;19:1182-90.
71. Raiskup F, Solomon A, Landau D, et al. Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol 2004;88:1425-8